PD2M Plenary Session Part 1, Expecting the Unexpected: Responses to Business Disruption in the Pharmaceutical Industry (Invited Talks) | AIChE

PD2M Plenary Session Part 1, Expecting the Unexpected: Responses to Business Disruption in the Pharmaceutical Industry (Invited Talks)

Chair(s)

Yazdanpanah, N., U.S. Food and Drug Administration

Co-chair(s)

Brettmann, B., Georgia Institute of Technology

This plenary session is composed of a panel of representatives for addressing responses to business disruption in the pharmaceutical industry. Panelists will discuss approaches used to address COVID-19 disruptions and other emergency cases with an eye towards lessons learned for building greater business resilience. Topics span discovery, manufacturing, supply chain, regulatory practices and remote work.

Presentations

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00